Stockholders' Equity and Share-Based Compensation - Additional Information 3 (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | 0 Months Ended | 3 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 28, 2013
Employees
|
Sep. 10, 2013
|
Apr. 27, 2010
Warrants [Member]
|
May 05, 2009
Warrants [Member]
|
Jun. 30, 2012
Warrants [Member]
|
Mar. 31, 2012
Warrants [Member]
|
Dec. 28, 2013
Warrants [Member]
|
Dec. 29, 2012
Warrants [Member]
|
Dec. 31, 2011
Warrants [Member]
|
Jul. 09, 2013
Stock Option Exchange Program [Member]
|
Dec. 28, 2013
Stock Option Exchange Program [Member]
|
Dec. 28, 2013
Stock Option Exchange Program [Member]
Stock Options Vest One Year [Member]
|
Dec. 28, 2013
Stock Option Exchange Program [Member]
Vest After One Year [Member]
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Exercise price of shares issued under exchange program | $ 1.83 | $ 4.00 | |||||||||||
Option exchange ratio | 3.5 to 1 | ||||||||||||
Shares issued under exchange program | 3,733,000 | ||||||||||||
Stock option exercise price, Minimum | $ 4.01 | ||||||||||||
Stock option exercise price, Maximum | $ 11.68 | ||||||||||||
Stock options vesting period | 4 years | ||||||||||||
Stock options vesting, description | The terms and conditions of the new options are subject to an entirely new four year vesting schedule where 25% will vest on the first anniversary, and the remaining 75% will vest monthly over the following 36 months. All new options have a ten year contractual term. | ||||||||||||
Stock options vested, Percentage | 25.00% | 75.00% | |||||||||||
Stock options vesting period maximum | 10 years | ||||||||||||
Stock options exercisable, number | 3,475,000 | ||||||||||||
Stock options exercised, Weighted average exercise price | $ 6.65 | ||||||||||||
Eligible employees | 45 | ||||||||||||
Option unvested exercisable number | 993,000 | 993,000 | |||||||||||
Option Nonvested Exercisable weighted average price | $ 0.9866 | ||||||||||||
Incremental fair value on the date of exchange | $ 422 | ||||||||||||
Vesting period of the new options | 4 years | ||||||||||||
Common stock warrants issued during period | 20,000 | 30,000 | |||||||||||
Warrant exercise price for warrants issued during period | 8.32 | 2.14 | |||||||||||
Termination period of warrants after grant date | 7 years | 7 years | |||||||||||
Warrants vest in equal monthly increments | 24 months | 36 months | |||||||||||
Increment of shares in warrant vest | 830 | 830 | |||||||||||
Grant date fair value of warrants issued during period | $ 2.12 | $ 1.09 | |||||||||||
Re-measured fair value of warrants | $ 3.14 | $ 1.42 | |||||||||||
Warrants exercised during period | 0 | ||||||||||||
Outstanding common stock warrants | 50,000 | ||||||||||||
Aggregate intrinsic value of outstanding and exercisable warrants | 11 | ||||||||||||
Share-based compensation expense recognized related to warrants | 0 | 16 | 65 | ||||||||||
Unrecognized share-based compensation expense related to warrants outstanding | $ 0 |